Karolinska Development AB (publ)

Stockholm Stock Exchange KDEV.ST

Karolinska Development AB (publ) Current Liabilities for the year ending December 31, 2023: USD 1.14 M

Karolinska Development AB (publ) Current Liabilities is USD 1.14 M for the year ending December 31, 2023, a 17.13% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Karolinska Development AB (publ) Current Liabilities for the year ending December 31, 2022 was USD 974.86 K, a -93.59% change year over year.
  • Karolinska Development AB (publ) Current Liabilities for the year ending December 31, 2021 was USD 15.21 M, a 39.77% change year over year.
  • Karolinska Development AB (publ) Current Liabilities for the year ending December 31, 2020 was USD 10.89 M, a -35.64% change year over year.
  • Karolinska Development AB (publ) Current Liabilities for the year ending December 31, 2019 was USD 16.91 M, a -69.12% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: KDEV.ST

Karolinska Development AB (publ)

CEO Dr. Viktor Drvota M.D., Ph.D.
IPO Date April 15, 2011
Location Sweden
Headquarters Tomtebodavägen 23 A
Employees 8
Sector Finance
Industries
Description

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.

Similar companies

BIOA-B.ST

BioArctic AB (publ)

USD 18.98

-4.07%

BINV.ST

BioInvent International AB (publ)

USD 2.43

-5.44%

ONCO.ST

Oncopeptides AB (publ)

USD 0.16

9.53%

MOB.ST

Moberg Pharma AB (publ)

USD 0.85

-1.32%

CANTA.ST

Cantargia AB (publ)

USD 0.16

-4.29%

StockViz Staff

February 5, 2025

Any question? Send us an email